SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-070335
Filing Date
2018-11-28
Accepted
2018-11-28 17:12:32
Documents
1
Period of Report
2018-11-27

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3386
  Complete submission text file 0001104659-18-070335.txt   4983
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Issuer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address
Business Address
PRICE MICHAEL DENNIS (Reporting) CIK: 0001247313 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17082 | Film No.: 181206345